1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow Peripheral T-Cell Lymphoma Refractory: new trials by email Literature Review of Peripheral T-Cell Lymphoma Refractory trials Research Report on Peripheral T-Cell Lymphoma Refractory
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma LB1901 - T-Cell Lymphoma, Peripheral T-Cell Lymphoma Refractory | Phase 1 | Unknown | Legend Biotech USA Inc | 50 | 2021-09-13 | 2023-10-03 |
Lymphoma, T-Cell (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
United States (1)